Cargando…
Alternol Sensitizes Renal Carcinoma Cells to TRAIL-Induced Apoptosis
Purpose: Tumor necrosis factor–related apoptosis-inducing ligand (TRAIL), a member of the TNF family, can selectively induce cancer cell death while sparing normal cells. However, the application of TRAIL-based antitumor therapies has been hindered due to drug resistance. Alternol is a new compound...
Autores principales: | Ren, Yu, Wang, Xue, Huang, Shuaishuai, Xu, Yangkai, Weng, Guobin, Yu, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026879/ https://www.ncbi.nlm.nih.gov/pubmed/33841136 http://dx.doi.org/10.3389/fphar.2021.560903 |
Ejemplares similares
-
Solamargine induces apoptosis of human renal carcinoma cells via downregulating phosphorylated STAT3 expression
por: Huang, Shuaishuai, et al.
Publicado: (2023) -
Alternol/Alteronol: Potent Anti-cancer Compounds With Multiple Mechanistic Actions
por: Liu, Wang, et al.
Publicado: (2020) -
Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs
por: Nalli, Ancy D., et al.
Publicado: (2018) -
Alternol triggers immunogenic cell death via reactive oxygen species generation
por: Li, Changlin, et al.
Publicado: (2021) -
Induction of cell cycle arrest by increasing GTP-RhoA levels via Taxol-induced microtubule polymerization in renal cell carcinoma
por: Ren, Yu, et al.
Publicado: (2017)